Class 2 recall-Lercanidipine HCl 20mg Tablets

We have received a Class 2 Recall from Recordati Industria Chimica e Farmaceutica S.p.A. on Lercanidipine HCl 20mg Tablets.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-lercanidipine-hcl-20mg-tablets-recordati-industria-el-25-a-slash-17?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=070d68eb-f056-4249-95fe-9701644771a1&utm_content=immediately

DMRC Ref: 35334038

Reason: “Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch of Lercanidipine HCl 20mg Tablets. The packs are incorrectly labelled as 10mg on some sides of the product carton when they are 20mg tablets.”

Please can you ensure that your stores quarantine the product listed below.

Further Information

For all medical information enquiries and information on this product, please email medinfo@recordati.co.uk, or telephone +353 (0)87 6245669. For stock control enquiries please email customerservice@recordati.com, or telephone 01491 576 336.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification (17/04/2025), cannot be reimbursed by way of a credit.